Ipca Laboratories (BOM:524494) Ending Cash Position : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Ending Cash Position?

Ipca Laboratories's Ending Cash Position for the quarter that ended in Dec. 2024 was ₹0 Mil.

Ipca Laboratories's annual Ending Cash Position increased from Mar. 2022 (₹9,909 Mil) to Mar. 2023 (₹15,790 Mil) but then declined from Mar. 2023 (₹15,790 Mil) to Mar. 2024 (₹7,558 Mil).

Ipca Laboratories Ending Cash Position Historical Data

The historical data trend for Ipca Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Ending Cash Position Chart

Ipca Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

2,953.90

5,590.10

9,909.30

15,789.80

7,557.90

Ipca Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Ipca Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ipca Laboratories's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	16554.8	+	-8996.9
	=	7,558

Ipca Laboratories's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Ipca Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Ending Cash Position

Traded in Other Exchanges

IPCALAB:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories Headlines

No Headlines